Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hematology Controls Market by Type (Low Control, Normal Control, High Control), By Application ( Hospital, Research Center & College, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hematology Controls Market by Type (Low Control, Normal Control, High Control), By Application ( Hospital, Research Center & College, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 129767 3300 Medical Devices & Consumables 377 240 Pages 4.8 (49)

Market Overview:

The global hematology controls market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of blood disorders, rising demand for hematology controls products from research centers and hospitals, and technological advancements in the field of hematology controls. However, factors such as high cost of advanced hematology controls products and limited reimbursement policies are restraining the growth of this market. Based on type, the global hematology controls market is segmented into low control, normal control, and high control segments. The low control segment is projected to account for a major share of the global market during the forecast period owing to its lower price point as compared to other types of controllers available in the market.

Global Hematology Controls Industry Outlook

Product Definition:

Hematology Controls are a set of laboratory tests used to measure the quality of blood cells and blood-forming tissues. They are used to ensure that these components are functioning properly and to diagnose problems with the blood or bone marrow.

Low Control:

Low control is a new term in the hematology market and it means lack of knowledge or skill with respect to the management of diseases, disorders, or health conditions. The major factor responsible for low control is lack of awareness among people regarding available diagnostic tests and treatments. Lack of information pertaining to disease causes results in delayed diagnosis and treatment which may lead to serious complications.

Normal Control:

Normal control is a method used to determine the effectiveness of hematology instruments and processes. It provides an average value for each parameter that can be used as a standard to compare results with. The normal range for each parameter is determined by testing millions of blood samples and creating an algorithm based on the median result.

The normal control segment has been growing rapidly in recent years due to its increasing demand from hospitals, laboratories, pharmaceutical companies, research institutes & universities.

Application Insights:

Based on the application, the market is segmented into hospital, research center & college and other. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as increasing prevalence of blood disorders and rising number of surgeries that require hematology analysis for proper diagnosis.

The research center & college application segment is expected to witness lucrative growth over the forecast period owing to increasing R&D activities pertaining to cancer and infectious diseases across various regions including North America, Latin America, Europe and Asia Pacific. For instance, according to data published by NCBI in 2018 regarding tuberculosis cases worldwide; it was estimated that there were approximately 10 million new TB cases every year with about 1-2 million deaths due primarily but not exclusively too old age groups (above 60 years) suffering from multidrug-resistant TB infection which accounts for majority of total TB cases globally along with a small percentage among young adults (aged 15-29 years).

Regional Analysis:

North America dominated the global hematology controls market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies & regulatory approvals. The U.S is one of the most lucrative markets for medical devices as it has a technologically advanced healthcare system and highly developed economy with well-established distribution channels.

In 2016, Europe accounted for 23% share in terms of revenue owing to its large geriatric population base that requires regular monitoring & testing along with an increase in chronic diseases prevalence rates such as cancer & blood disorders among others which results into higher control volumes consumed within this region over past few years (2013-2016).

Growth Factors:

  • Increasing incidence of blood disorders and cancer
  • Growing demand for hematology controls in research laboratories and hospitals
  • Technological advancements in hematology controls industry
  • Rising awareness about early diagnosis and treatment of blood disorders
  • Increasing number of mergers and acquisitions in the global hematology controls market

Scope Of The Report

Report Attributes

Report Details

Report Title

Hematology Controls Market Research Report

By Type

Low Control, Normal Control, High Control

By Application

 Hospital, Research Center & College, Other

By Companies

Diatron, Cardinal Health, Thermo Fisher, Sysmex, Beckman, Abbott, Horiba, Siemens, Bio-Rad, Boule, Mindray

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Hematology Controls Market Report Segments:

The global Hematology Controls market is segmented on the basis of:


Low Control, Normal Control, High Control

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


 Hospital, Research Center & College, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Diatron
  2. Cardinal Health
  3. Thermo Fisher
  4. Sysmex
  5. Beckman
  6. Abbott
  7. Horiba
  8. Siemens
  9. Bio-Rad
  10. Boule
  11. Mindray

Global Hematology Controls Market Overview

Highlights of The Hematology Controls Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Low Control
    2. Normal Control
    3. High Control
  1. By Application:

    1.  Hospital
    2. Research Center & College
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hematology Controls Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hematology Controls Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Hematology controls are a set of measures taken to maintain the health of your blood. Hematology includes everything related to blood, including red and white blood cells, platelets, and plasma.

Some of the key players operating in the hematology controls market are Diatron, Cardinal Health, Thermo Fisher, Sysmex, Beckman, Abbott, Horiba, Siemens, Bio-Rad, Boule, Mindray.

The hematology controls market is expected to grow at a compound annual growth rate of 5.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Hematology Controls Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Hematology Controls Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Hematology Controls Market - Supply Chain
   4.5. Global Hematology Controls Market Forecast
      4.5.1. Hematology Controls Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Hematology Controls Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Hematology Controls Market Absolute $ Opportunity

5. Global Hematology Controls Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Hematology Controls Market Size and Volume Forecast by Type
      5.3.1. Low Control
      5.3.2. Normal Control
      5.3.3. High Control
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Hematology Controls Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Hematology Controls Market Size and Volume Forecast by Application
      6.3.1.  Hospital
      6.3.2. Research Center & College
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Hematology Controls Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Hematology Controls Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Hematology Controls Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Hematology Controls Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Hematology Controls Demand Share Forecast, 2019-2029

9. North America Hematology Controls Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Hematology Controls Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Hematology Controls Market Size and Volume Forecast by Application
      9.4.1.  Hospital
      9.4.2. Research Center & College
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Hematology Controls Market Size and Volume Forecast by Type
      9.7.1. Low Control
      9.7.2. Normal Control
      9.7.3. High Control
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Hematology Controls Demand Share Forecast, 2019-2029

10. Latin America Hematology Controls Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Hematology Controls Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Hematology Controls Market Size and Volume Forecast by Application
      10.4.1.  Hospital
      10.4.2. Research Center & College
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Hematology Controls Market Size and Volume Forecast by Type
      10.7.1. Low Control
      10.7.2. Normal Control
      10.7.3. High Control
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Hematology Controls Demand Share Forecast, 2019-2029

11. Europe Hematology Controls Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Hematology Controls Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Hematology Controls Market Size and Volume Forecast by Application
      11.4.1.  Hospital
      11.4.2. Research Center & College
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Hematology Controls Market Size and Volume Forecast by Type
      11.7.1. Low Control
      11.7.2. Normal Control
      11.7.3. High Control
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Hematology Controls Demand Share, 2019-2029

12. Asia Pacific Hematology Controls Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Hematology Controls Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Hematology Controls Market Size and Volume Forecast by Application
      12.4.1.  Hospital
      12.4.2. Research Center & College
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Hematology Controls Market Size and Volume Forecast by Type
      12.7.1. Low Control
      12.7.2. Normal Control
      12.7.3. High Control
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Hematology Controls Demand Share, 2019-2029

13. Middle East & Africa Hematology Controls Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Hematology Controls Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Hematology Controls Market Size and Volume Forecast by Application
      13.4.1.  Hospital
      13.4.2. Research Center & College
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Hematology Controls Market Size and Volume Forecast by Type
      13.7.1. Low Control
      13.7.2. Normal Control
      13.7.3. High Control
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Hematology Controls Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Hematology Controls Market: Market Share Analysis
   14.2. Hematology Controls Distributors and Customers
   14.3. Hematology Controls Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Diatron Overview Financials Developments Strategic Outlook
      14.4.2. Cardinal Health Overview Financials Developments Strategic Outlook
      14.4.3. Thermo Fisher Overview Financials Developments Strategic Outlook
      14.4.4. Sysmex Overview Financials Developments Strategic Outlook
      14.4.5. Beckman Overview Financials Developments Strategic Outlook
      14.4.6. Abbott Overview Financials Developments Strategic Outlook
      14.4.7. Horiba Overview Financials Developments Strategic Outlook
      14.4.8. Siemens Overview Financials Developments Strategic Outlook
      14.4.9. Bio-Rad Overview Financials Developments Strategic Outlook
      14.4.10. Boule Overview Financials Developments Strategic Outlook
      14.4.11. Mindray Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us